Reported Oct 7, 2020 · Terminated

Buprenorphine Transdermal System 5 mcg/hour, 4 transdermal systems/4 disposal units per carton, Rx Only, Manufactured…

Teva Pharmaceuticals USA

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

What you should do

Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.

Firm contact: Teva Pharmaceuticals USA · 400 Interpace Pkwy · Parsippany, NJ · 07054-1120

Is this the product you have?

  • Buprenorphine Transdermal System 5 mcg/hour, 4 transdermal systems/4 disposal units per carton, Rx Only
  • Manufactured by
    • 3M Drug Delivery Systems
    • 19901 Nordhoff street
    • Northridge
    • CA 91324 USA
  • Manufactured forTeva Pharmaceuticals USA Inc., North Wales, PA 19454
  • carton NDC0093-3656-40
  • patch NDC0093-3656-21
Lot codes and dates
    • Lot # 190017
    • exp. 02/2021
    • 190161
    • exp. 08/2021
Amount recalled
32,543 cartons

Where it was sold

  • Nationwide
  • PR

Why it was recalled

Failed Stability Specifications: Below specification result for buprenorphine release rate.

This product could cause temporary or reversible health problems — stop using it.

Want the full recall guide?

The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.

Free recall alerts

Get alerted about new Teva Pharmaceuticals USA recalls

One email when a matching recall is published. No account, no cost, unsubscribe in one click.

Where this came from

Source: U.S. Food & Drug Administration (openFDA)

Read the FDA (openFDA drug enforcement) notice

Notice updated Aug 26, 2021 · Data as of Sep 19, 5:08 PM UTC

RecallNow is not a government agency. Every fact on this page is published by the FDA, USDA or CPSC and links back to their notice.